Tekcapital - 500 Beiträge pro Seite

[heinzconrad]

Ich bin die Tage auf eine hochspekulative Investmentgesellschaft im University Intellectual Property
https://www.tekcapital.com/intro/ gestoßen.

TEKCAPITAL IS A UNIQUE IP INVESTMENT COMPANY. WE ACQUIRE AND COMMERCIALISE TECHNOLOGIES DEVELOPED BY OUR GLOBAL UNIVERSITY NETWORK.

https://www.londonstockexchange.com/exchange/news/market-new…

Sie wird mit einem deutlichen Abschlag zu ihren Beteiligungen gehandelt (45% des NAV).
http://www.alignresearch.co.uk/tekcapital/tekcapital-update-…

[heinzconrad]

Antwort auf Beitrag Nr.: 58.437.145 von heinzconrad am 13.08.18 17:54:00

Tekcapital’s Lucyd smartglass venture receives US.1mln in blockchain token event

Eine der Beteiligungen Lucyd smartglass venture hat einen erfolgreichen ICO gemacht:

Tekcapital’s Lucyd smartglass venture receives US$6.1mln in blockchain token event

http://www.proactiveinvestors.co.uk/companies/news/192409/te…

[heinzconrad]

Das Unternehmen hat zwei Standorte, eines davon im Oxford Science Park

UK HEADQUARTERS

JOHN ECCLES HOUSE
ROBERT ROBINSON AVENUE
OXFORD SCIENCE PARK
OXFORD, OX4 4GP

und

US OFFICE

12000 BISCAYNE BLVD, SUITE 222
NORTH MIAMI, FL, 33181
UNITED STATES

[Hufeisenmagnet]

und was willst Du uns jetzt sagen ?

[heinzconrad]

Antwort auf Beitrag Nr.: 58.437.763 von Hufeisenmagnet am 13.08.18 19:14:24

Gar nichts will ich sagen, über Rückmeldung und Diskussion über das Unternehmen freue ich mich

[heinzconrad]

Aktuelle Halbjahreszahlen

https://www.londonstockexchange.com/exchange/news/market-new…

der Net asset value ist bei US$0.25, während der aktuelle Kurs bei ca 0,12 britische Pfund liegt... (12 GBX)


Half Yearly Report

for the period ending 31 May 2018



Tekcapital plc (AIM: TEK) a UK intellectual property (IP) investment group focused on creating marketplace value from university technology announces its results for the six month period ended 31 May 2018.



Financial highlights

· Total revenue of US$1,278,413

o Revenue from services increased by c. 29% to US$639,561 (H1 2017: $495,8761) reflecting continued growth of technology transfer services

o Net increase of US$638,852 in fair value of portfolio companies

· Profit before tax of US$105,996 compared to profit of US$1,554,796 in H1 2017, with the change primarily due to first-time recognition of fair value of portfolio companies in H1 2017.

· Cash balance of US$1,418,889 (30 November 2017:US$1,797,729) and no debt

· Net assets up 35% at 31 May 2018: US$10,746,031 (H1 2017: 7,974,906)

· Net asset per share at 31 May 2018: US$0.25 (H1 2017: US$0.19).



Operational highlights: Corporate

· Investment in the Latin America market has resulted in the expansion of Invention Evaluator (IE) sales and business relationships with the following universities and organisations:

o Universidad San Sebastian

o Universidad Mayor

o Fundacion COPEC

o Universidad Adolfo Ibañez

o Andes Pacific Technology Access Hub

o Corfo (Chilean economic development agency)

o Universidad Federico Santa María

o INACAP

o Universidad Santiago de Chile



· Global expansion of our technology transfer services was aided by the addition of new lines of sales:

o Invention Evaluator has developed a new report at the request of StartUp Chile, the leading startup accelerator in Latin America. Start-Up Chile supports several hundred companies a year, and these reports would assist their start-up companies on an on-going basis. Management believes this new IE report will further strengthen growth in services revenue in future periods.



o Successfully developed and delivered an advanced technology commercialization programme in Santiago, Chile with HUB APTA and the Chilean Biotechnology Association. This programme will provide training services, Invention Evaluator reports and our software apps to our Chilean customers. The programme included participants from 13 Chilean research universities and two other research institutions. The sponsor of this unique programme was the Chilean government Agency CORFO, the main Chilean agency focused on entrepreneurship, innovation and competitiveness. University training programmes represent a new line of service business for Tekcapital, and we are optimistic about delivering more of them in future periods.



· Tekcapital has recently appointed Michael S Rosen as Managing Director of Academic & Entrepreneurship Training to accelerate the growth of our Latin America business. Mr. Rosen has worked with leading research universities where he has trained university faculty on the creation of start-ups. Previously, he held senior management positions with Fortune 500 companies such as Pfizer, Bristol-Myers Squibb and Searle/Monsanto. Mr. Rosen also spent 12 years as President/CEO of European and U.S. biotech and medical device companies. He is fluent in both Spanish and Portuguese.



Operational highlights: Portfolio Companies



· Belluscura has reported continued progress with its portable oxygen concentrator (POC) programme. The POC market is currently projected to reach US$1.7b by 2022. Belluscura plans to file a 510(K) application with the US FDA in 2018. Tekcapital's ownership interest in Belluscura is now 8,129,488 shares, representing approximately 33% of the issued share capital.



· During the reporting period, Belluscura plc completed a private funding round raising gross proceeds of US$1.33 million, by way of a placing (the Belluscura Placing) of a total of 7,388,179 new ordinary shares of £0.13p each (the Belluscura Placing Shares). Tekcapital has invested US$250,000 in the private placement and converted loans to Belluscura of US$210,090 to equity. Tekcapital also received a three-year warrant to purchase 1,273,078 new shares in Belluscura at £0.13p per share.



· As announced on 5 February 2018, Belluscura also added a Vice President of Operations, Dr. Paul Bray, PhD. Amongst other duties Dr. Bray is working on the FDA clearance process. To learn more, please visit www.belluscura.com.



· Lucyd pte ltd ("Lucyd") completed a Token Generation event (TGE) to secure contributions of approximately $6m for the development of augmented reality (AR) smartglasses and execution of its business plan. Lucyd is seeking to introduce a prototype AR product in March 2019. The market for AR is expected to grow to US$36.4b by 2023 according to Greenlight Insights. Lucyd recently announced it has appointed Gina Avila as Global Marketing Manager.



· Lucyd pte ltd announced on 4 July 2018 that Lucyd Pte Ltd has appointed Dr Ira A. Clement, a licensed optometrist, as a science advisor.



· Lucyd has filed a new Patent Application No. 16/022,097 to improve the utility of Augmented Reality glasses. The application is directed to smartglasses, with prescription lenses, and methods to control the presentation and display of information related to mobile device tasks that can be performed with these smartglasses.



· On August 3, 2018 Lucyd launched an eShop to make it easy for anyone to acquire advanced prescription eyewear or smart glasses and to create, share and experience AR content. The eShop is the first online optics store to provide prescription filled, bone conducting, Bluetooth enabled eyeglasses that enable the wearer to answer their phone, listen to music and communicate with Siri® or other similar AI apps. To learn more, please visit www.lucyd.co.



· Salarius has developed a patented process for producing nano-particle edible salt crystals. Independent tests have shown that the use of its edible salt crystals for topical food applications can deliver the same taste but half of the sodium versus traditional salt. The mission of Salarius is to commercialize low-sodium Microsalt to improve the nutritional content of food and the health of individuals worldwide. To achieve this mission, the company is exploring the launch of both a low-sodium table salt and the establishment of a reduced sodium snack brand. The low sodium ingredient market is estimated to reach US$1.76bn by 2025 according to Future Market Insights.2



· Salarius announced on 22 May 2018 that it has also added Eduardo Souchon and Steve McCready to its board of directors, both with relevant Fortune 500 company experience.



· Victor H. Manzanilla has been appointed as CEO of Salarius as announced on 1 August 2018. Mr Manzanilla has previously served as founder of VHM Global Research, Marketing Director of Office Depot (office products chain with approximately 1,400 stores) and Brand Manager at Procter & Gamble (NYSE: PG) amongst other executive positions. Additionally, Mr Manzanilla has purchased 2.5% of the shares of Salarius through his consulting firm VHM Global Research for $50,000.



Dr. Clifford Gross, Chairman said: 'We are pleased to report successful half-year performance for the Group, which has noted increases in service revenue while achieving important development milestones for the successful commercialization of technologies for three of its portfolio companies. We believe our unique approach of acquiring and commercialising university IP innovations, coupled with providing a range of IP value creation services to universities and corporates, has uniquely positioned us to create market value from university discoveries more efficiently than traditional IP investment companies.'

[startvestor]

Antwort auf Beitrag Nr.: 58.442.497 von heinzconrad am 14.08.18 12:03:00

Der Kurs fällt und fällt. Was gefällt dem Markt nicht?

[startvestor]

Antwort auf Beitrag Nr.: 59.336.393 von startvestor am 30.11.18 17:06:58

Der Markt mag die Firma überhaupt nicht, könnte auch mit dem Brexit zu tun haben. Kurs weiter gefallen, NAV gestiegen.

Hier gibts mehr Infos im Forum:

https://www.lse.co.uk/ShareChat.asp?ShareTicker=TEK&share=Te…

[ader]

Ja der Kurs fällt mittlerweile ins Bodenlose.

Über 50% seit der Eröffnung hier.

Wo wäre denn eurer Meinung nach ein Boden ???